From: Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer
 | Ki67 densityb | Perforin densityb | ||||||
---|---|---|---|---|---|---|---|---|
na | low | high | P-valuec | na | low | high | P-valuec | |
Immune cell markers: | ||||||||
 Immune topography T-cells (CD3/CD4) | ||||||||
  hot | 26 | 8 | 18 | 0.102 | 26 | 9 | 17 | 0.049 |
  cold | 29 | 17 | 12 | 28 | 19 | 9 | ||
  excluded | 37 | 19 | 18 | 35 | 17 | 18 | ||
 Immune topography T-cells (CD3/CD8) | ||||||||
  hot | 27 | 7 | 20 | 0.025 | 26 | 7 | 19 | 0.006 |
  cold | 31 | 18 | 13 | 30 | 21 | 9 | ||
  excluded | 34 | 19 | 15 | 33 | 17 | 16 | ||
 Immune topography B-cells (CD79A) | ||||||||
  hot | 9 | 3 | 6 | 0.317 | 8 | 5 | 3 | 0.504 |
  cold | 7 | 5 | 2 | 6 | 4 | 2 | ||
  excluded | 80 | 39 | 41 | 78 | 37 | 41 | ||
 Immune topography macrophages (CD68/CD163) | ||||||||
  hot | 27 | 11 | 16 | 0.224 | 27 | 12 | 15 | 0.165 |
  cold | 29 | 18 | 11 | 28 | 18 | 10 | ||
  excluded | 38 | 17 | 21 | 36 | 15 | 21 | ||
 Immune topography all immune cells | ||||||||
  hot | 28 | 8 | 20 | 0.039 | 27 | 11 | 16 | 0.292 |
  cold | 32 | 16 | 16 | 31 | 19 | 12 | ||
  excluded | 31 | 19 | 12 | 30 | 15 | 15 |